Top Industry Leaders in the Periodontal Therapeutic Market
Latest Periodontal Therapeutic Companies Update
Dentsply Sirona introduces Perio-Shield™ Plus Gel: This January 2024 launch offers a new topical chlorhexidine gel for plaque control and gum support, potentially expanding treatment options for dentists and patients.
OraPharma Announces FDA Clearance for Evomin, a Novel Gum Disease Treatment: This December 2023 milestone provides a new non-antibiotic, topical option for gingivitis management, potentially impacting market dynamics.
Amyndas Pharmaceuticals reports positive Phase 2b results for AMY-101: This October 2023 study showcases the potential of AMY-101, a novel oral peptide, for treating both gingivitis and periodontitis, sparking further research and development interest.
University of California, San Diego researchers develop microfluidic chip for early periodontitis detection: This January 2024 breakthrough could pave the way for more accurate and rapid diagnosis, leading to earlier intervention and improved treatment outcomes.
List of Periodontal Therapeutic Key companies in the market
- Fibrocell Sciences
- Tolmar Inc
- Eli Lilly & Company
- Align Technology
- Dentsply International
- 3M-ESPE
- Ultradent Products Inc
- Nobel Biocare Holdings AG
- Glidewell Laboratories
- Orapharma
- Kaken Pharmaceutical
- Valeant Pharmaceuticals Int.,
